Measuring the Symptoms of Pediatric Constipation and Irritable Bowel Syndrome with Constipation: Expert Commentary and Literature Review

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Background

Symptom measurement in pediatric chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) trials requires appropriately developed clinical outcome assessments (COAs).

Methods

Literature was reviewed to identify symptom COAs meeting regulatory standards. Searches were conducted in Pubmed/Medline, EMBASE, and PsychINFO. Title/abstracts were reviewed to identify qualitative studies and those using COAs to measure pediatric CIC/IBS symptoms. Pediatric functional gastrointestinal experts provided input on relevant symptom-concepts to measure.

Results

Review of 1,105 abstracts identified 1 relevant qualitative article and 113 articles including COAs. Symptoms most frequently measured in CIC studies were frequency of bowel movements, fecal incontinence/encopresis, abdominal pain, stool consistency, and painful defecation. Symptoms most frequently measured in IBS were abdominal pain, abdominal distention/bloating, stool consistency, frequency of bowel movements, and gas. Evidence of development/validity of COAs was limited. Expert feedback was broadly consistent with the literature.

Conclusion

Findings demonstrate consistency in the literature on key CIC/IBS symptoms to measure in pediatric trials, but existing COAs do not meet regulatory standards.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006;101(10):2401–9.

    PubMed  Article  Google Scholar 

  2. 2.

    Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006;130(5):1519–26.

    PubMed  Article  Google Scholar 

  3. 3.

    Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr. 1996;129(2):220–6.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    van den Berg MM, van Rossum CH, de Lorijn F, Reitsma JB, Di Lorenzo C, Benninga MA. Functional constipation in infants: a follow-up study. J Pediatr. 2005;147(5):700–4.

    PubMed  Article  Google Scholar 

  5. 5.

    Loening-Baucke V, Miele E, Staiano A. Fiber (glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics. 2004;113(3 Pt 1):e259–64.

    PubMed  Article  Google Scholar 

  6. 6.

    Liem O, Mousa H, Benninga M, Di L. Tegaserod use in children: a single-center experience. J Pediatr Gastroenterol Nutr. 2008;46(1):54–8.

    PubMed  Article  Google Scholar 

  7. 7.

    Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130(5):1527–37.

    PubMed  Article  Google Scholar 

  8. 8.

    Khoshoo V, Armstead C, Landry L. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23(1):191–6.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Hyams JS, Treem WR, Justinich CJ, Davis P, Shoup M, Burke G. Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 1995;20(2):209–14.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    FDA. Clinical Outcome Assessment (COA): glossary of terms, 2013. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm370262.htm#pro.

  11. 11.

    FDA Guidance for Industry: Patient-reported outcome measures: use in medical product development to support labeling claims. 2009.

  12. 12.

    Leidy NK, Vernon M. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. PharmacoEconomics. 2008;26(5):363–70.

    PubMed  Article  Google Scholar 

  13. 13.

    Reeve BB, Wyrwich KW, Wu AW, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013;22(8):1889–905.

    PubMed  Article  Google Scholar 

  14. 14.

    Walker L, Sorrells S. Brief report: assessment of children’s gastrointestinal symptoms for clinical trials. J Pediatr Psychol. 2002;27(3):303–7.

    PubMed  Article  Google Scholar 

  15. 15.

    Matza LS, Patrick DL, Riley AW, et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health. 2013;16(4):461–79.

    PubMed  Article  Google Scholar 

  16. 16.

    EMEA. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medical products. 2005; http://www.emea.europa.eu. Accessed 27 Sept 2011.

  17. 17.

    Blum N, Taubman B, Nemeth N. During toilet training, constipation occurs before stool toileting refusal. Pediatrics. 2004;113(6):e520.

    PubMed  Article  Google Scholar 

  18. 18.

    Chao H, Vandenplas Y. Therapeutic effect of Novalac-IT in infants with constipation. Nutrition (Burbank Los Angeles County Calif). 2007;23(6):469–73.

    CAS  Article  Google Scholar 

  19. 19.

    Bahar R, Collins B, Steinmetz B, Ament M. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152(5):685–9.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Claar R, Walker L, Smith C. Functional disability in adolescents and young adults with symptoms of irritable bowel syndrome: the role of academic, social, and athletic competence. J Pediatr Psychol. 1999;24(3):271–80.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Kuttner L, Chambers C, Hardial J, Israel D, Jacobson K, Evans K. A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag. 2006;11(4):217–23.

    PubMed Central  PubMed  Google Scholar 

  22. 22.

    Chitkara D, Bredenoord A, Cremonini F, et al. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol. 2004;99(8):1579–84.

    PubMed  Article  Google Scholar 

  23. 23.

    Thomson S, Dancey CP. Symptoms of irritable bowel in school children: prevalence and psychosocial effects. J Pediatr Health Care. 1996;10(6):280–5.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Endo Y, Shoji T, Fukudo S, et al. The features of adolescent irritable bowel syndrome in Japan. J Gastroenterol Hepatol. 2011;26(Suppl 3):106–9.

    PubMed  Article  Google Scholar 

  25. 25.

    Endo Y, Shoji T, Tamura D, Sato Y, Machida T, Fukudo S. Abdominal symptoms are changeable in adolescent irritable bowel syndrome: two-year follow up study. Psychother Psychosom. 2013;82:27–8.

    Google Scholar 

  26. 26.

    Rajindrajith S, Devanarayana NM. Subtypes and symptomatology of irritable bowel syndrome in children and adolescents: a school-based survey using Rome III criteria. J Neurogastroenterol Motil. 2012;18(3):298–304.

    PubMed Central  PubMed  Article  Google Scholar 

  27. 27.

    Kalani A, Griem A, Crebassa L, et al. A simple intervention program markedly decreases resource utilization for adolescents with irritable bowel syndrome (IBS). Am J Gastroenterol. 2012;107:S700–1.

    Google Scholar 

  28. 28.

    Scarpellini E, Giorgio V, Gabrielli M, et al. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome: a preliminary study. Eur Rev Med Pharmacol Sci. 2013;17(10):1314–20.

    CAS  PubMed  Google Scholar 

  29. 29.

    Varni J, Lane M, Burwinkle T, et al. Health-related quality of life in pediatric patients with irritable bowel syndrome: a comparative analysis. J Dev Behav Pediatr. 2006;27(6):451–8.

    PubMed  Article  Google Scholar 

  30. 30.

    Di Nardo G, Barbara G, Cucchiara S, et al. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. Neurogastroenterol Motil. 2014;26(2):196–204.

    PubMed  Article  Google Scholar 

  31. 31.

    Giannetti E, Turco R, Miele E, et al. Prospective observational study on the prevalence of subtypes of irritable bowel syndrome in children at diagnosis and changes of these subtypes at follow-up. Dig Liver Dis. 2012;44:S128–9.

    Article  Google Scholar 

  32. 32.

    Isoldi S, Di Nardo G, Barbara G, et al. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. Dig Liver Dis. 2013;45:e270.

    Article  Google Scholar 

  33. 33.

    Chumpitazi BP, Weidler EM, Shulman RJ. Adolescent irritable bowel syndrome (IBS) represents a unique subset of childhood IBS. Gastroenterology. 2012;142(5):S-382. doi:10.1016/S0016-5085(12)61447-4.

  34. 34.

    Di Nardo G, Barbara G, Oliva S, et al. Efficacy and tolerability of alpha-galactosidase on gas related symptoms in pediatric irritable bowel syndrome. A randomized, double-blind, placebo controlled trial. Dig Liver Dis. 2011;43:S412.

    Article  Google Scholar 

  35. 35.

    Guandalini S, Magazzu G, Chiaro A, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51(1):24–30.

    PubMed  Article  Google Scholar 

  36. 36.

    Bonamico M, Culasso F, Colombo C, et al. Irritable bowel syndrome in children: an Italian multicentre study. Ital J Gastroenterol. 1995;27(1):13–20.

    CAS  PubMed  Google Scholar 

  37. 37.

    Devitt P, Thornley E, Hinks M. An evaluation of an inter-disciplinary constipation clinic for childhood constipation. J Res Nurs. 2007;12(5):539–47.

    Article  Google Scholar 

  38. 38.

    Caplan A, Walker L, Rasquin A. Development and preliminary validation of the questionnaire on pediatric gastrointestinal symptoms to assess functional gastrointestinal disorders in children and adolescents. J Pediatr Gastroenterol Nutr. 2005;41:296–304.

    PubMed  Article  Google Scholar 

  39. 39.

    Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol. 1993;28(8):681–7.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129–34.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Clayden GS, Keshtgar AS, Carcarni-Rathwell I, Abhyankar A. The management of chronic constipation and related faecal incontinence in childhood. Arch Dis Child Ed Pract. 2005;90:58–67.

    Google Scholar 

  42. 42.

    Lakshminarayanan B, Kufeji D, Clayden G. A new ultrasound scoring system for assessing the severity of constipation in children. Pediatr Surg Int. 2008;24(12):1379–84.

    PubMed  Article  Google Scholar 

  43. 43.

    Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol. 1995;90(3):366–71.

    CAS  PubMed  Google Scholar 

  44. 44.

    Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990;65(11):1456–79.

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Walker LS, Smith CA, Garber J, Van Slyke DA. Development and validation of the pain response inventory for children. Psychol Assess. 1997;9(4):392.

    Article  Google Scholar 

  46. 46.

    Voskuijl WP, van der Zaag-Loonen HJ, Ketel IJG, Grootenhuis MA, Derkx BHF, Benninga MA. Health related quality of life in disorders of defecation: the Defecation Disorder List. Arch Dis Child. 2004;89(12):1124–7.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  47. 47.

    Fichtner F, Sailer M, Höcht B. Development of a new scoring for the evaluation of incontinence and constipation in children. Coloproctology. 2003;25(1):10–5.

    Article  Google Scholar 

  48. 48.

    Clawson E. Fears in children with chronic constipation: reliability and validity of the Defecation Anxiety Scale. Diss Abstr Int Sect B Sci Eng. 1997;57(9-B):5910.

    Google Scholar 

  49. 49.

    Cox DJ, Sutphen J, Ling W, Quillian W, Borowitz S. Additive benefits of laxative, toilet training, and biofeedback therapies in the treatment of pediatric encopresis. J Pediatr Psychol. 1996;21(5):659–70.

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Cox D, Ritterband L, Quillian W, et al. Assessment of behavioral mechanisms maintaining encopresis: Virginia Encopresis-Constipation Apperception Test. J Pediatr Psychol. 2003;28(6):375–82.

    PubMed  Article  Google Scholar 

  51. 51.

    Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43(2):400–11.

    CAS  PubMed  Article  Google Scholar 

  52. 52.

    Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95(4):999–1007.

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Eiser C. Psychological effects of chronic disease. J Child Psychol Psychiatry. 1990;31:85–98.

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Shinozaki M, Kanazawa M, Sagami Y, et al. Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol. 2006;41(5):491–4.

    PubMed  Article  Google Scholar 

  55. 55.

    Ball T, Weydert J. Methodological challenges to treatment trials for recurrent abdominal pain in children. Arch Pediatr Adolesc Med. 2003;157(11):1121–7.

    PubMed  Article  Google Scholar 

  56. 56.

    Derogatis LR. SCL-90: an outpatient psychiatric rating scale. Preliminary report. Psychopharmacol Bull. 1974;9:13–28.

    Google Scholar 

  57. 57.

    Saps M, Sztainberg M, Di L. A prospective community-based study of gastroenterological symptoms in school-age children. J Pediatr Gastroenterol Nutr. 2006;43(4):477–82.

    PubMed  Article  Google Scholar 

  58. 58.

    Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain. 2001;93(2):173–83.

    CAS  PubMed  Article  Google Scholar 

  59. 59.

    Vogels T, Verrips GHW, Koopman HM, Theunissen NCM, Fekkes M, Kamphuis RP. TACQOL manual. Parent and child form. 2000.

  60. 60.

    Faleiros F, Machado N. Assessment of health-related quality of life in children with functional defecation disorders. J Pediatr. 2006;82(6):421–5.

    Google Scholar 

  61. 61.

    Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800–12.

    CAS  PubMed  Article  Google Scholar 

  62. 62.

    Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37(2):126–39.

    CAS  PubMed  Article  Google Scholar 

  63. 63.

    Roblin N. Assessment of the effectiveness of paediatric psychoeducational programs on family functioning. Diss Abstr Int Sect A Humanit Soc Sci. 2000;60(8-A):2820.

    Google Scholar 

  64. 64.

    Achenbach TM. Child behavior checklist/4-18. 1991.

  65. 65.

    Aksnes G, Diseth T, Helseth A, et al. Appendicostomy for antegrade enema: effects on somatic and psychosocial functioning in children with myelomeningocele. Pediatrics. 2002;109(3):484–9.

    PubMed  Article  Google Scholar 

  66. 66.

    Seligman LD, Ollendick TH, Langley AK, Baldacci HB. The utility of measures of child and adolescent anxiety: a meta-analytic review of the revised children’s manifest anxiety scale, the state-trait anxiety inventory for children, and the child behavior checklist. J Clin Child Adolesc Psychol. 2004;33(3):557–65.

    PubMed  Article  Google Scholar 

  67. 67.

    Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581–6.

    CAS  PubMed  Article  Google Scholar 

  68. 68.

    March JS, Sullivan K. Test-retest reliability of the Multidimensional Anxiety Scale for Children. J Anxiety Disord. 1999;13(4):349–58.

    CAS  PubMed  Article  Google Scholar 

  69. 69.

    Walker LS, Greene JW. The functional disability inventory: measuring a neglected dimension of child health status. J Pediatr Psychol. 1991;16(1):39–58.

    CAS  PubMed  Article  Google Scholar 

  70. 70.

    Muller-Lissner S, Koch G, Talley NJ, et al. Subject’s Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. J Clin Epidemiol. 2003;56(4):310–6.

    PubMed  Article  Google Scholar 

  71. 71.

    Sakano Y. Verification of validity of General Self-Efficacy Scale (GSES). Waseda J Hum Sci. 1989;2:91–8.

    Google Scholar 

  72. 72.

    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.

    PubMed  Article  Google Scholar 

  73. 73.

    Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res. 1998;7(5):399–407.

    CAS  PubMed  Article  Google Scholar 

  74. 74.

    Ravens-Sieberer U, Gosch A, Rajmil L, et al. KIDSCREEN-52 quality-of-life measure for children and adolescents. Expert Rev Pharmacoecon Outcomes Res. 2005;5(3):353–64.

    PubMed  Article  Google Scholar 

  75. 75.

    Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr. 2005;147(2):197–201.

    PubMed  Article  Google Scholar 

  76. 76.

    Castilloux J, Noble A, Faure C. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders? J Pediatr Gastroenterol Nutr. 2008;46(3):272–8.

    PubMed  Article  Google Scholar 

  77. 77.

    Caplan A, Walker L, Rasquin A. Validation of the pediatric Rome II criteria for functional gastrointestinal disorders using the questionnaire on pediatric gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2005;41(3):305–16.

    PubMed  Article  Google Scholar 

  78. 78.

    Ravens-Sieberer U, Herdman M, Devine J, et al. The European KIDSCREEN approach to measure quality of life and well-being in children: development, current application, and future advances. Qual Life Res. 2014;23(3):791–803.

    PubMed Central  PubMed  Article  Google Scholar 

  79. 79.

    Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990;41(2):139–50.

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Arbuckle R, Abetz-Webb L. “Not just little adults”: qualitative methods to support the development of pediatric patient-reported outcomes. Patient. 2013;6(3):143–59.

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

The authors thank the following expert physicians who participated and shared their views in the Expert Advisory Meeting reported in this article: Warren P. Bishop, Carlo Di Lorenzo, Jeffrey S. Hyams, Paul Hyman, Anthony Lembo, Adrian Miranda, and Miguel Saps.

Disclosure of financial arrangements

This research was funded by Forest Research Institute and Ironwood Pharmaceuticals.

Conflict of interest

Robert Arbuckle, Linda Abetz-Webb, and Elizabeth Gargon are employees of Adelphi Values (or were employees at the time the research was conducted), a health outcomes agency contracted by Forest Research Institute and Ironwood Pharmaceuticals to perform the research. Robyn Carson and Steven Shiff are employees of Forest Research Institute. Barbara Lewis, Caroline Kurtz, and Jeffrey Johnston are employees of Ironwood Pharmaceuticals (or were employees at the time the research was conducted). Jeffrey Hyams and Carlo Di Lorenzo were independent consultants contracted by Forest Research Institute and Ironwood Pharmaceuticals for their participation in the research.

Author contributions

Robert Arbuckle, Linda Abetz-Webb, and Elizabeth Gargon contributed to the study design, performed the literature review, and prepared the first draft of the manuscript. Robyn Carson, Jeffrey Hyams, Carlo Di Lorenzo, Barbara Lewis, Caroline Kurtz, Steven Shiff, and Jeffrey Johnston contributed to the design of the study, provided strategic input into the literature review, and reviewed and approved the manuscript. Rob Arbuckle acts as the overall guarantor for this manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Robert A. Arbuckle.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 79 kb)

Supplementary material 2 (DOC 75 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Arbuckle, R.A., Carson, R.T., Abetz-Webb, L. et al. Measuring the Symptoms of Pediatric Constipation and Irritable Bowel Syndrome with Constipation: Expert Commentary and Literature Review. Patient 7, 343–364 (2014). https://doi.org/10.1007/s40271-014-0070-3

Download citation

Keywords

  • Irritable Bowel Syndrome
  • Patient Report Outcome
  • Bowel Movement
  • Irritable Bowel Syndrome Patient
  • Stool Consistency